Low-dose CT scan

RADIATION3 trials

Sponsors

Ottawa Hospital Research Institute, Guardant Health, Inc., University Hospital, Antwerp

Conditions

Femoroacetabular ImpingementHip DysplasiaLung CancerLung Cancer, Nonsmall CellLung Cancer, Small CellOsteoarthritisSmoking Cessation

Phase 2

Cam Type FAI is a Cause of Hip Pain in the Young Adult and a Precursor to OA

RecruitingNCT04080466

Ottawa Hospital Research InstituteFemoroacetabular Impingement, Hip Dysplasia, Osteoarthritis

Start: 2021-02-20End: 2025-01-31Target: 58Updated: 2024-01-05

Unknown Phase

Screening for High Frequency Malignant Disease

Active, not recruitingNCT05117840

Guardant Health, Inc.Lung Cancer

Start: 2022-01-13End: 2026-07-30Target: 12000Updated: 2026-04-03

Implementation of Lung Cancer Screening in the First Line Zone of ZORA (Flanders), Using a Low Dose CT-scan

University Hospital, AntwerpLung Cancer, Lung Cancer, Nonsmall Cell, Lung Cancer, Small Cell +1

Start: 2024-09-01End: 2026-01-01Target: 700Updated: 2024-03-05

Related Papers

Screening for high frequency malignant disease (SHIELD).

Journal of Clinical Oncology2023-06-011 citations

Abstract 2141: Development of a highly-sensitive targeted cell-free DNA epigenomic assay for early-stage multi-cancer screening

Cancer Research2022-06-153 citations

Development of a highly sensitive multicancer, targeted, cell-free DNA epigenomic assay for integrated screening of lung and colorectal cancer.

Journal of Clinical Oncology2022-06-013 citations

Screening for high frequency malignant disease (SHIELD).

Journal of Clinical Oncology2022-06-012 citations